Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

66.5K
Overview
66.5K
Autoimmune Disorders01:29

Autoimmune Disorders

358
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
358
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same author

Medulloblastoma immune microenvironment resembles early brain development and reveals novel basophil- B cell- associated signatures.

Neuro-oncology advances·2026
Same author

The intermediate-risk gap in AI-based breast cancer stratification - Authors' reply.

The Lancet. Oncology·2026
Same author

Local and global microstructural and functional thalamomotor connectivity alterations in Parkinson's disease following motor learning.

NPJ Parkinson's disease·2026
Same author

Neural correlates of Parkinson's improvements after combined digital-levodopa therapy: a pilot study.

Brain communications·2026
Same author

The genetic and clinical characteristics of oculopharyngeal muscular dystrophy patients in Israel.

Orphanet journal of rare diseases·2026
Same journal

Mechanistic constraints in dengue severity: a systematic review with evidence stratification and agent-based evaluation of logical sufficiency.

Frontiers in immunology·2026
Same journal

Circadian control of immune homeostasis in cardiovascular health and disease.

Frontiers in immunology·2026
Same journal

An IHC-derived TLS-CD8-macrophage immune niche score predicts major pathological response to neoadjuvant chemoimmunotherapy in resectable NSCLC.

Frontiers in immunology·2026
Same journal

AF6 orchestrates macrophage polarization via JAK2-STAT3 signaling and supports intestinal regeneration by stimulating stem cell proliferation.

Frontiers in immunology·2026
Same journal

Restoring immune homeostasis in the spinal microenvironment: targeting mechano-inflammation and immunometabolic reprogramming.

Frontiers in immunology·2026
Same journal

A self-perpetuating neuron-intrinsic GSDMD-mtDNA-AIM2 inflammasome axis drives neuronal pyroptosis and cognitive impairment after traumatic brain injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: May 17, 2025

Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

13.7K

Survival and autoimmune risks post-thymectomy.

Irina Tsirkin1, Mohamed Khateb2, Dvir Aran3,4

  • 1Department of Neurology, Assuta Medical Center, Ashdod, Israel.

Frontiers in Immunology
|April 4, 2025
PubMed
Summary
This summary is machine-generated.

Thymectomy benefits outweigh risks for myasthenia gravis (MG) and thymic malignancy patients. Incidental thymectomy should be avoided, especially for non-neoplastic conditions, to prevent adverse outcomes.

Keywords:
autoimmune diseasemortalitymyasthenia gravisthymectomythymic pathology

More Related Videos

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

16.5K
A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

29.9K

Related Experiment Videos

Last Updated: May 17, 2025

Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

13.7K
Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

16.5K
A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

29.9K

Area of Science:

  • Medical research
  • Thoracic surgery
  • Immunology

Background:

  • Recent studies questioned thymectomy's safety, not exclusively in myasthenia gravis (MG) patients.
  • This study investigates thymectomy's effects across patient groups, irrespective of MG status.

Purpose of the Study:

  • To evaluate the safety and outcomes of thymectomy in patients with and without myasthenia gravis (MG).
  • To compare thymectomy's impact on mortality, autoimmune diseases, and cancer incidence in different patient cohorts.

Main Methods:

  • Retrospective case-control study analyzing clinical and radiological data from 2010-2023.
  • Four patient groups were analyzed: MG with thymectomy (MG-Thy), MG without thymectomy (MG-NO-Thy), non-MG with thoracoscopic surgery (Surgery-NO-Thy), and non-MG with thymectomy (Non-MG-Thy).
  • Statistical analysis of patient demographics, thymic pathology, mortality rates, and post-procedure disease incidence.

Main Results:

  • The MG-Thy group exhibited the lowest mortality rate (0 deaths).
  • Thymectomy in MG patients was associated with zero post-thymectomy cancer incidence.
  • Non-MG patients undergoing thymectomy showed higher rates of thymic malignancies and mortality compared to MG-Thy patients.

Conclusions:

  • Thymectomy offers significant benefits for patients with MG and thymic malignancies, outweighing potential risks.
  • Incidental thymectomy, particularly in non-neoplastic cases, should be avoided due to increased risks.
  • Reevaluation of thymectomy indications is recommended, especially for non-neoplastic conditions.